search
Back to results

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

Primary Purpose

Dermatitis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%
Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5%
Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5%
Silwet* DA-63 (Momentive) 1.5%
Sodium lauryl sulfate (Sigma Aldrich) 1.0%
Water (control)
Sponsored by
Kimberly-Clark Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Dermatitis

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy Subjects with Fitzpatrick Skin Types I, II or III

Exclusion Criteria:

  • Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color

Sites / Locations

  • Reliance Clinical Testing Service

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Surfactant Exposure

Arm Description

PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5% Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5% Silwet* DA-63 (Momentive) 1.5% Sodium lauryl sulfate (Sigma Aldrich) 1.0% Water

Outcomes

Primary Outcome Measures

Type of microbes present on skin after exposure to various surfactants
Microbes will be identified by metagenomic sequencing
Amount of microbes present on skin after exposure to various surfactants

Secondary Outcome Measures

Full Information

First Posted
October 30, 2015
Last Updated
September 26, 2016
Sponsor
Kimberly-Clark Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02615912
Brief Title
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
Official Title
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
Study Type
Interventional

2. Study Status

Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
February 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kimberly-Clark Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction between the skin microbiome and the epidermis after exposure to surfactants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dermatitis

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Surfactant Exposure
Arm Type
Other
Arm Description
PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5% Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5% Silwet* DA-63 (Momentive) 1.5% Sodium lauryl sulfate (Sigma Aldrich) 1.0% Water
Intervention Type
Other
Intervention Name(s)
PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%
Intervention Type
Other
Intervention Name(s)
Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5%
Intervention Type
Other
Intervention Name(s)
Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5%
Intervention Type
Other
Intervention Name(s)
Silwet* DA-63 (Momentive) 1.5%
Intervention Type
Other
Intervention Name(s)
Sodium lauryl sulfate (Sigma Aldrich) 1.0%
Intervention Type
Other
Intervention Name(s)
Water (control)
Primary Outcome Measure Information:
Title
Type of microbes present on skin after exposure to various surfactants
Description
Microbes will be identified by metagenomic sequencing
Time Frame
4 days
Title
Amount of microbes present on skin after exposure to various surfactants
Time Frame
4 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Subjects with Fitzpatrick Skin Types I, II or III Exclusion Criteria: Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Barry Reece, MBA
Organizational Affiliation
RCTS, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Reliance Clinical Testing Service
City
Irving
State/Province
Texas
ZIP/Postal Code
75062
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
11525947
Citation
Loffler H, Pirker C, Aramaki J, Frosch PJ, Happle R, Effendy I. Evaluation of skin susceptibility to irritancy by routine patch testing with sodium lauryl sulfate. Eur J Dermatol. 2001 Sep-Oct;11(5):416-9.
Results Reference
background
PubMed Identifier
24152302
Citation
Hoffman DR, Kroll LM, Basehoar A, Reece B, Cunningham CT, Koenig DW. Immediate and extended effects of sodium lauryl sulphate exposure on stratum corneum natural moisturizing factor. Int J Cosmet Sci. 2014 Feb;36(1):93-101. doi: 10.1111/ics.12101. Epub 2013 Nov 20.
Results Reference
background
PubMed Identifier
18007579
Citation
Torma H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol. 2008 May;128(5):1212-9. doi: 10.1038/sj.jid.5701170. Epub 2007 Nov 15.
Results Reference
background
PubMed Identifier
19860898
Citation
Wolcott RD, Gontcharova V, Sun Y, Dowd SE. Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol. 2009 Oct 27;9:226. doi: 10.1186/1471-2180-9-226.
Results Reference
background
PubMed Identifier
18652685
Citation
Dowd SE, Callaway TR, Wolcott RD, Sun Y, McKeehan T, Hagevoort RG, Edrington TS. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol. 2008 Jul 24;8:125. doi: 10.1186/1471-2180-8-125.
Results Reference
background
PubMed Identifier
19052515
Citation
Wolcott RD, Dowd SE. A rapid molecular method for characterising bacterial bioburden in chronic wounds. J Wound Care. 2008 Dec;17(12):513-6. doi: 10.12968/jowc.2008.17.12.31769.
Results Reference
background

Learn more about this trial

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

We'll reach out to this number within 24 hrs